Impact of Concomitant Non-Cancer Medications on Outcomes in Breast Cancer

An evaluation of non-cancer medications used concomitantly with cancer therapies for patients with breast cancer showed that proton pump inhibitors specifically were associated with worse survival outcomes and with an increased risk of grade…